03.30.23
Anita Johansen has been appointed as the new chief executive officer of Probi, a global supplier specializing in probiotics, effective April 1.
Johansen has been employed with Probi since April 2022 as the vice president of R&D, and served in the role of interim CEO since December 2022. Johansen has more than 30 years of leadership experience in the product development segment of nutritional and probiotic products. Prior to joining Probi, she held senior leadership positions in Pfizer Consumer Healthcare, Novozymes OneHealth, and USP Zdrowie. Johansen holds a master’s degree in pharmacy and a PhD in pharmaceutical technology, both from the Danish University of Pharmaceutical Sciences (now University of Copenhagen) in Denmark.
“I am confident that Anita Johansen with her proven leadership skills, solid scientific and probiotic experience as well as her strong business acumen will be able to lead and support the Probi team and further strengthen the pace of innovation and manufacturing excellence and bring the company back on a profitable growth trajectory”, said Jean-Yves Parisot, chairman of the board.
“I am honored and delighted to accept the opportunity to become chief executive officer of Probi,” Johansen said. “During my previous 12 months in Probi I have become only more convinced of the fundamental strengths and the clear growth potential of our company, and I will be focused on working with the entire Probi team to deliver improved business results. I share the same passion for people and probiotics as my predecessors, and I look forward to continuing in the same spirit as the probiotic pioneers of Probi.”
Johansen has been employed with Probi since April 2022 as the vice president of R&D, and served in the role of interim CEO since December 2022. Johansen has more than 30 years of leadership experience in the product development segment of nutritional and probiotic products. Prior to joining Probi, she held senior leadership positions in Pfizer Consumer Healthcare, Novozymes OneHealth, and USP Zdrowie. Johansen holds a master’s degree in pharmacy and a PhD in pharmaceutical technology, both from the Danish University of Pharmaceutical Sciences (now University of Copenhagen) in Denmark.
“I am confident that Anita Johansen with her proven leadership skills, solid scientific and probiotic experience as well as her strong business acumen will be able to lead and support the Probi team and further strengthen the pace of innovation and manufacturing excellence and bring the company back on a profitable growth trajectory”, said Jean-Yves Parisot, chairman of the board.
“I am honored and delighted to accept the opportunity to become chief executive officer of Probi,” Johansen said. “During my previous 12 months in Probi I have become only more convinced of the fundamental strengths and the clear growth potential of our company, and I will be focused on working with the entire Probi team to deliver improved business results. I share the same passion for people and probiotics as my predecessors, and I look forward to continuing in the same spirit as the probiotic pioneers of Probi.”
